These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 32683399

  • 1. Corpus callosum index correlates with brain volumetry and disability in multiple sclerosis patients.
    Sugijono SE, Mulyadi R, Firdausia S, Prihartono J, Estiasari R.
    Neurosciences (Riyadh); 2020 Jul; 25(3):193-199. PubMed ID: 32683399
    [Abstract] [Full Text] [Related]

  • 2. Correlation between the corpus callosum index and brain atrophy, lesion load, and cognitive dysfunction in multiple sclerosis.
    Gonçalves LI, Dos Passos GR, Conzatti LP, Burger JLP, Tomasi GH, Zandoná MÉ, Azambuja LS, Gomes I, Franco A, Sato DK, Becker J.
    Mult Scler Relat Disord; 2018 Feb; 20():154-158. PubMed ID: 29414290
    [Abstract] [Full Text] [Related]

  • 3. MRI-Defined Corpus Callosal Atrophy in Multiple Sclerosis: A Comparison of Volumetric Measurements, Corpus Callosum Area and Index.
    Granberg T, Bergendal G, Shams S, Aspelin P, Kristoffersen-Wiberg M, Fredrikson S, Martola J.
    J Neuroimaging; 2015 Feb; 25(6):996-1001. PubMed ID: 25786805
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Deep gray matter volume loss drives disability worsening in multiple sclerosis.
    Eshaghi A, Prados F, Brownlee WJ, Altmann DR, Tur C, Cardoso MJ, De Angelis F, van de Pavert SH, Cawley N, De Stefano N, Stromillo ML, Battaglini M, Ruggieri S, Gasperini C, Filippi M, Rocca MA, Rovira A, Sastre-Garriga J, Vrenken H, Leurs CE, Killestein J, Pirpamer L, Enzinger C, Ourselin S, Wheeler-Kingshott CAMG, Chard D, Thompson AJ, Alexander DC, Barkhof F, Ciccarelli O, MAGNIMS study group.
    Ann Neurol; 2018 Feb; 83(2):210-222. PubMed ID: 29331092
    [Abstract] [Full Text] [Related]

  • 7. Gray matter atrophy in multiple sclerosis despite clinical and lesion stability during natalizumab treatment.
    Koskimäki F, Bernard J, Yong J, Arndt N, Carroll T, Lee SK, Reder AT, Javed A.
    PLoS One; 2018 Feb; 13(12):e0209326. PubMed ID: 30576361
    [Abstract] [Full Text] [Related]

  • 8. Corpus callosum index and long-term disability in multiple sclerosis patients.
    Yaldizli O, Atefy R, Gass A, Sturm D, Glassl S, Tettenborn B, Putzki N.
    J Neurol; 2010 Aug; 257(8):1256-64. PubMed ID: 20198382
    [Abstract] [Full Text] [Related]

  • 9. Brain atrophy and physical disability in primary progressive multiple sclerosis: A volumetric study.
    Galego O, Gouveia A, Batista S, Moura C, Machado E.
    Neuroradiol J; 2015 Jun; 28(3):354-8. PubMed ID: 26246109
    [Abstract] [Full Text] [Related]

  • 10. Corpus callosum atrophy is strongly associated with cognitive impairment in multiple sclerosis: Results of a 17-year longitudinal study.
    Granberg T, Martola J, Bergendal G, Shams S, Damangir S, Aspelin P, Fredrikson S, Kristoffersen-Wiberg M.
    Mult Scler; 2015 Aug; 21(9):1151-8. PubMed ID: 25480866
    [Abstract] [Full Text] [Related]

  • 11. Corpus callosum axon diameter relates to cognitive impairment in multiple sclerosis.
    Huang SY, Fan Q, Machado N, Eloyan A, Bireley JD, Russo AW, Tobyne SM, Patel KR, Brewer K, Rapaport SF, Nummenmaa A, Witzel T, Sherman JC, Wald LL, Klawiter EC.
    Ann Clin Transl Neurol; 2019 May; 6(5):882-892. PubMed ID: 31139686
    [Abstract] [Full Text] [Related]

  • 12. Cervical cord area is associated with infratentorial grey and white matter volume predominantly in relapsing-remitting multiple sclerosis: A study using semi-automated cord volumetry and voxel-based morphometry.
    Bellenberg B, Schneider R, Weiler F, Suchan B, Haghikia A, Hoffjan S, Gold R, Köster O, Lukas C.
    Mult Scler Relat Disord; 2015 May; 4(3):264-72. PubMed ID: 26008944
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Fast whole-brain three-dimensional macromolecular proton fraction mapping in multiple sclerosis.
    Yarnykh VL, Bowen JD, Samsonov A, Repovic P, Mayadev A, Qian P, Gangadharan B, Keogh BP, Maravilla KR, Jung Henson LK.
    Radiology; 2015 Jan; 274(1):210-20. PubMed ID: 25208343
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Grey matter atrophy in patients with benign multiple sclerosis.
    Niiranen M, Koikkalainen J, Lötjönen J, Selander T, Cajanus A, Hartikainen P, Simula S, Vanninen R, Remes AM.
    Brain Behav; 2022 Jul; 12(7):e2679. PubMed ID: 35765699
    [Abstract] [Full Text] [Related]

  • 17. A validation study of manual atrophy measures in patients with Multiple Sclerosis.
    Cappelle S, Pareto D, Tintoré M, Vidal-Jordana A, Alyafeai R, Alberich M, Sastre-Garriga J, Auger C, Montalban X, Rovira À.
    Neuroradiology; 2020 Aug; 62(8):955-964. PubMed ID: 32246177
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Appraisal of cerebral atrophy in multiple sclerosis by means of the corpus callosum index].
    Perez-Alvarez AI, Garcia-Rua A, Suarez-Santos P, Castanon-Apilanez M, Ameijide-Sanluis E, Saiz-Ayala A, Meilan-Martinez A, Villafani-Echazu WJ, Gonzalez-Delgado M, Oliva-Nacarino P.
    Rev Neurol; 2018 Dec 01; 67(11):417-424. PubMed ID: 30484274
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.